Technology Investment & Licensing

Therapeutics

Here's a sample of UniQuest's projects looking for commercial partners. If you would like more information on a project, let us know you're interested using the Quick Query form.

  1. Coridon - skin cancer platform gene technology
  2. Helmedix - Helminth defence molecules
  3. TheraPhil - neutropenia therapy
  4. Chronic Lymphocytic Leukaemia Therapy
  5. Targeted Anti-Restenotic Therapy
  6. Adipochange - obesity therapeutic target
  7. Tolergentide - multiple sclerosis therapy
  8. MegaMSCs - industrial stem cells
  9. MSPep - multiple sclerosis therapy
  10. Q-Pharm Pty Ltd - quality pharmaceutical research
  11. Engineered Gal2 - immune-related disease modulator
  12. Dendright Pty Ltd - Rheumatoid Arthritis vaccine

Sign up to receive all the latest news about UniQuest's investment and licensing portfolio with The Deal Sheet, or visit our News pages.

Back to Research Innovation Portfolio